Literature DB >> 29764467

Association of IL17RC and COL6A1 genetic polymorphisms with susceptibility to ossification of the thoracic posterior longitudinal ligament in Chinese patients.

Peng Wang1, Xiao Liu1, Bin Zhu2, Yunlong Ma1, Lei Yong1, Ze Teng3, Chen Liang1, Guanping He1, Xiaoguang Liu4.   

Abstract

BACKGROUND: In our previous whole-genome sequencing study of 30 unrelated northern Chinese Han patients, we identified six single nucleotide polymorphisms (SNPs) in the interleukin 17 receptor C (IL17RC) and collagen type VI α1 chain (COL6A1) genes that were potentially associated with thoracic ossification of the posterior longitudinal ligament (T-OPLL). To determine whether these six SNPs are associated with susceptibility to T-OPLL in the northern Chinese Han population, we performed a case-control association study to confirm specific susceptible loci in the expanded samples.
METHODS: The six SNPs in the IL17RC and COL6A1 genes were analyzed in 200 northern Chinese individuals (100 patients and 100 control subjects) using the Sequenom system.
RESULTS: The genotype distributions and allele frequencies of each SNP in the control and patient groups were compared. rs201153092, rs13051496, rs199772854, rs76999397, and rs189013166 showed potential pathogenic loci for T-OPLL in the northern Chinese Han population, whereas rs151158105 did not. At the genotype level, the differences in the genotype frequencies of rs201153092, rs13051496, rs199772854, rs76999397, and rs189013166 between T-OPLL cases and controls reached statistical significance.
CONCLUSIONS: To the best of our knowledge, this is the first association study of susceptibility genes in Han Chinese patients with T-OPLL. The results revealed five SNPs in the IL17RC and COL6A1 genes that represented potentially pathogenic mutations in patients with T-OPLL.

Entities:  

Keywords:  Association study; COL6A1; IL17RC; Ossification of the posterior longitudinal ligament; Thoracic

Mesh:

Substances:

Year:  2018        PMID: 29764467      PMCID: PMC5952594          DOI: 10.1186/s13018-018-0817-y

Source DB:  PubMed          Journal:  J Orthop Surg Res        ISSN: 1749-799X            Impact factor:   2.359


Background

Ossification of the posterior longitudinal ligament (OPLL), which involves pathological heterotopic ossification of this region, can lead to symptoms of spinal cord compression and radiculopathy in affected patients. The disease has a marked ethnic predilection, with epidemiological studies suggesting that OPLL is found almost exclusively in Japanese, Chinese, and Korean individuals [1]. Approximately 70% of OPLL cases affect the cervical spine, whereas 15% occur in the thoracic spine [2]. Ohtsuka et al. reported that the prevalence of thoracic OPLL (T-OPLL) in Japanese individuals is 0.8%, which is lower than that of cervical OPLL (3.2%) [3]. Although the most common site of OPLL is the cervical spine, T-OPLL is considered more severe. As T-OPLL is slowly progressive, the majority of patients develop symptoms only when the disease progresses to an advanced stage, when severe spinal cord injury occurs. Clinical manifestations include sensory disturbances, dyskinesia, fecal and urinary incontinence, and even paraplegia. The disability rate in T-OPLL is much higher than that in cervical OPLL. Currently, treatment approaches for T-OPLL are limited, and surgery is the only effective treatment. However, owing to the unusual blood supply and anatomical structure associated with this disease, surgery for T-OPLL is complicated; it is difficult to avoid surgical complications, and the risk of paralysis is extremely high. The optimal surgical methods for T-OPLL, as well as the timing of the surgery, remain controversial, thus it remains a challenge for clinicians to perform timely and effective treatment of the disease [4]. Genetics are considered to be a predominant factor in the etiology of OPLL. Several East Asian groups have performed candidate gene linkage and association studies, which have suggested that a number of polymorphisms in osteogenic genes are associated with the occurrence and development of cervical OPLL. To date, 16 genes/loci that are linked to OPLL susceptibility have been reported [5], including toll-like receptor 5 (TLR5) [6], collagen type XII α2 chain (COL11A2) [7], COL6A1 [8-10], runt-related transcription factor 2 (RUNX2) [11], bone morphogenetic protein 2 (BMP2) [12], bone morphogenetic protein 4 (BMP4) [13], transforming growth factor β1 (TGFB1) [14], interleukin 1β (IL1B) [15], and interleukin 15 receptor subunit α (IL15RA) [16]. However, these findings have not been sufficiently reproducible, and usually only one SNP was examined to evaluate the gene, and thus there is a lack of linkage disequilibrium (LD) studies on multiple single nucleotide polymorphisms (SNPs) [17]. In addition, no genetic studies have assessed the causes of T-OPLL. In our previous whole-genome sequencing (WGS) study of 30 unrelated northern Chinese Han patients, four different algorithms [including SIFT(http://sift.jcvi.org/) [18], PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/) [19], MutationTaster (http://www.mutationtaster.org/) [20], and GERP++ (http://mendel.stanford.edu/SidowLab/downloads/gerp/) [21]] were used to predict deleterious variations at different SNP loci. We found that rs201153092 was predicted to be deleterious by four algorithms, rs199772854 was predicted by three algorithms, and rs151158105, rs13051496, rs76999397, and rs189013166 were predicted by two algorithms (Table 1). In the present study, we aimed to identify genetic factors for T-OPLL by performing a case-control study of six SNPs in two genes (COL6A1 and IL17RC) potentially associated with susceptibility to T-OPLL in the northern Chinese Han population.
Table 1

Mutation findings for 30 patients with T-OPLL by WGS

GeneSNP IDChromosomeNucleotide changeProtein change1000G (EAS)SIFTPP2MutationTasterGERR++
COL6A1rs20115309221c.1534G>Ap.Gly512Ser0DDDR
COL6A1rs1305149621c.2669C>Tp.Ser890Leu0TBDR
COL6A1rs15115810521c.1298G>Ap.Arg433Gln0DBNR
IL17RCrs1997728543c.2275C>Ap.Leu759Ile0DDNR
IL17RCrs769993973c.1908G>Ap.Ala636Ala0.00378DBNR
IL17RCrs1890131663c.2238G>Ap.Gly746Gly0DBNR

1000G (EAS), 1000 Genomes (Asian); SIFT (D deleterious, T tolerated); PP2, Polyphen-2 (D probably damaging, P possibly damaging, B benign); MutationTaster (D disease causing, N polymorphism); GERP++ (R rejected substitutions, S substitutions)

Mutation findings for 30 patients with T-OPLL by WGS 1000G (EAS), 1000 Genomes (Asian); SIFT (D deleterious, T tolerated); PP2, Polyphen-2 (D probably damaging, P possibly damaging, B benign); MutationTaster (D disease causing, N polymorphism); GERP++ (R rejected substitutions, S substitutions)

Methods

Case selection and grouping

The study protocol was approved by the Ethics Committee for Human Subjects of the Peking University Third Hospital. Informed consent was provided by all participating individuals. A total of 100 unrelated northern Chinese Han T-OPLL patients with myelopathy and/or neurological dysfunction [47 men (mean age, 51.00 ± 3.30 years) and 53 women (mean age, 52.34 ± 6.09 years)] and 100 sex-matched unrelated healthy controls [45 men (mean age, 55.84 ± 3.06 years) and 55 women (mean age, 54.36 ± 5.69 years)] were enrolled in this study between January 2010 and October 2016. Diagnosis of T-OPLL was performed by specialists based on clinical symptoms and radiological examinations (including computed tomography and magnetic resonance imaging) of the thoracic spine. The appearance of OPLL observed on the radiographs was classified into four subtypes: (i) segmental, (ii) continuous, (iii) mixed, and (iv) local [22]. Individuals who had lumbar spondylolisthesis, ankylosing spondylitis, diffuse idiopathic skeletal hyperostosis, and disc herniation of the thoracic spine were included in the study, and none were taking any drugs known to affect bone or calcium metabolism.

SNP selection and genotyping

EDTA-anticoagulated peripheral blood samples were obtained from all participants for DNA extraction. Genomic DNA samples were extracted from peripheral leukocytes with the standard procedure using a Wizard Genomic DNA Purification Kit (Promega Corporation, Madison, WI, USA). Six SNPs distributed among the two genes were selected based on findings from our previous WGS studies. The polymerase chain reaction (PCR) fragments were submitted for Sanger sequencing at the Beijing Genomics Institute, and the forward and reverse sequence reads were assembled and analyzed in DNAStar version 7.1. Details of the six studied SNPs and the primer sequences are listed in Table 2. The six primers were used for PCR as described previously [23]. PCR was performed with 20 ng genomic DNA per 15-μl reaction mixture, containing 0.2 μM of each primer, 200 μM of deoxyribonucleotides, 50 mM KCl, 10 mM Tris HCl (pH 8.3), 1.5 mM MgCl2, and 0.5 units of Taq DNA polymerase in a DNA Gradient PCR machine (Bio-Rad Laboratories, Inc., Hercules, CA, USA). The thermocycling conditions were as follows: initial denaturation at 95 °C for 10 min; followed by 35 cycles of 95 °C for 30 s, annealing at an assay-specific temperature (48 °C to 65 °C) for 45 s, and elongation at 72 °C for 45 s; and a final terminal elongation step at 72 °C for 5 min. The PCR products were analyzed by direct sequencing using a BigDye Terminator v3.1 Cycle Sequencing Kit (Thermo Fisher Scientific, Inc., Waltham, MA, USA) with POP-7™ Polymer in a 3730XL DNA Analyzer with Sequencing Analysis Software version 5.2 (Thermo Fisher Scientific, Inc., Waltham, MA, USA).
Table 2

Details of the six SNPs in COL6A1 and IL17RC and their associated primers

GeneSNP IDNucleotide substitution (M/m)Primer sequence
COL6A1 rs201153092G/AForward 5′-TGAAAGGGTGAGTGTCCAA-3′Reverse 5′-GTGCCCAGTCCACTAAAGAG-3′
COL6A1 rs13051496C/TForward 5′-AGCCACAACTTTGACACCA-3′Reverse 5′-GAAGCGGGTCACATAGCC-3′
COL6A1 rs151158105G/AForward 5′-CCTCCTGCCCAAGACA-3′Reverse 5′-TCCAAAGAAGAACCCAAGC-3′
IL17RC rs199772854C/AForward 5′-CCCAACTGCCAGACTTCCT-3′Reverse 5′-GCCACAGCCTGCGTAAAA-3′
IL17RC rs76999397G/AForward 5′-GGCTCTGCTCCTCTACTCAG-3′Reverse 5′-AATGACGTTTGCCAGCCC-3′
IL17RC rs189013166G/AForward 5′-GGCTCTGCTCCTCTACTCAG-3′Reverse 5′-AATGACGTTTGCCAGCCC-3′
Details of the six SNPs in COL6A1 and IL17RC and their associated primers

Statistical analysis

All statistical analyses were performed using SPSS v17.0 software (SPSS, Inc., Chicago, IL, USA). The χ2 test was used to determine whether individual variants were in equilibrium at each locus in the population (Hardy-Weinberg equilibrium), as well as the genotypic and allelic distributions. Pairwise LD was calculated as D′ and R2 using Haploview version 4.2. The Pearson’s χ2 test was used to determine the correlation between the variants and the disease based on the odds ratios (ORs) with 95% confidence intervals (95% CI). All statistical tests were two-sided, and significance was set at P < 0.05.

Results

Six SNPs were genotyped among northern Chinese Han subjects. With the exception of rs151158105, which was incompatible with the Hardy-Weinberg equilibrium (P = 0.005), the remaining five SNPs were in Hardy-Weinberg equilibrium (P > 0.05). The allelic frequencies and genotype distributions of the six studied SNPs are shown in Tables 3 and 4. rs201153092, rs13051496, rs199772854, rs76999397, and rs189013166 showed significant associations with T-OPLL (P < 0.05). The A allele frequency of rs201153092 was higher in T-OPLL cases (8.5%) than in controls (0.5%). The T allele frequency of rs13051496 was higher in T-OPLL cases (5.5%) than in controls (1.0%). The A allele frequency of rs199772854 was higher in T-OPLL cases (6%) than in controls (1.0%). The A allele frequency of rs76999397 was higher in T-OPLL cases (4.5%) than in controls (1.0%). The A allele frequency of rs189013166 was higher in T-OPLL cases (4.0%) than in controls (0.5%).
Table 3

Allelic frequencies of the six SNPs

SNP ID N Allele frequency (%)Versus control
Major alleleMinor alleleP valueaOdds ratio (95% CI)
rs201153092GA
 Cases10091.508.500.00011418.49 (2.436–140.3)
 Controls10099.500.50
rs13051496CT
 Cases10094.505.500.011165.762 (1.26–26.34)
 Controls10099.001.00
rs151158105GA
 Cases10099.500.500.3167
 Controls100100.000.00
rs199772854CA
 Cases10094.006.000.0065156.319 (1.396–28.61)
 Controls10099.001.00
rs76999397GA
 Cases10095.504.500.032344.665 (0.9951–21.87)
 Controls10099.001.00
rs189013166GA
 Cases10096.004.000.018278.292 (1.027–66.92)
 Controls10099.500.50

N number of subjects

aAllele frequency difference between cases and controls

Table 4

Genotype frequencies of the six SNPs

SNP ID N Genotype frequency (%)Versus control
MMMmmmP valueaP valueb
rs201153092GGGAAA
 Cases100831700.00007707
 Controls1009910
rs13051496CCCTTT
 Cases100891100.009838
 Controls1009820
rs151158105GGGAAA
 Cases10099100.3161
 Controls10010000
rs199772854CCCAAA
 Cases100881200.005582
 Controls1009820
rs76999397GGGAAA
 Cases10090.919.0900.02992
 Controls1009820
rs189013166GGGAAA
 Cases10092800.01696
 Controls1009910

N number of subjects

aDominant model: (major allele homozygote + heterozygote)/minor allele homozygote

bRecessive model: major allele homozygote/(minor allele homozygote + heterozygote)

Allelic frequencies of the six SNPs N number of subjects aAllele frequency difference between cases and controls Genotype frequencies of the six SNPs N number of subjects aDominant model: (major allele homozygote + heterozygote)/minor allele homozygote bRecessive model: major allele homozygote/(minor allele homozygote + heterozygote) At the genotype level, the differences in the genotype frequencies at rs201153092, rs13051496, rs199772854, rs76999397, and rs189013166 reached statistical significance between T-OPLL cases and controls (recessive model; P = 0.00007707, P = 0.009838, P = 0.005582, P = 0.02992, and P = 0.01696, respectively). No significant difference was observed in the genotype or allele frequencies of rs151158105 between T-OPLL cases and controls. The LD coefficients among rs201153092, rs151158105, and rs13051496 ranged from 0.91 to 1, and the R2 value ranged from 0.05 to 0.6 (Table 5). The LD coefficients among rs199772854, rs76999397, and rs189013166 were 1, and the R2 value ranged from 0.63 to 0.81 (Table 6).
Table 5

Linkage disequilibrium statistics among IL17RC SNPs (D′/R2)

SNP IDrs76999397rs189013166rs199772854
rs769993970.810.78
rs18901316610.63
rs19977285411
Table 6

Linkage disequilibrium statistics among COL6A1 SNPs (D′/R2)

SNP IDrs151158105rs201153092rs13051496
rs1511581050.050.07
rs20115309210.6
rs1305149610.91
Linkage disequilibrium statistics among IL17RC SNPs (D′/R2) Linkage disequilibrium statistics among COL6A1 SNPs (D′/R2)

Discussion

OPLL is a condition that is characterized by the calcification of the soft tissues that connect the bones of the spine. Although the exact underlying cause is currently unknown, it has been suggested that it is a multifactorial condition that is influenced by several different genetic and environmental factors [17]. The accumulation of deleterious missense mutations in individual human genomes has been proposed to form the genetic basis of complex diseases [24], and WGS is considered to be a promising approach for the study of such diseases [5]. In the present study, we performed association studies to confirm specific susceptibility loci in expanded samples. In this study, rs201153092 and rs13051496 in COL6A1 were potential pathogenic loci for T-OPLL in the northern Chinese Han population. According to our data, the A allele frequency of rs201153092 was higher in T-OPLL cases than controls, which implied that the A allele could be a risk factor for the genetic susceptibility to T-OPLL and that the “GA” genotype enhanced the probability of the occurrence of T-OPLL. The T allele frequency of rs13051496 was higher in T-OPLL cases than in controls, which implied that the T allele could be a risk factor for the genetic susceptibility to T-OPLL and that the “CT” genotype enhanced the probability of T-OPLL susceptibility. COL6A1, which encodes the α1 chain of type VI collagen, is located on chromosome 21q22.3 and spans approximately 23.3 kbp. COL6A1 encodes an extracellular matrix protein that may serve as a scaffold for osteoblastic or preosteoblastic cells or chondrocytes that subsequently undergo membranous or endochondral ossification [25]. Although the functional impacts of rs201153092 and rs13051496 in COL6A1 in bone metabolism remain elusive, the molecular variants of these extracellular proteins may be implicated in the ectopic bone formation observed in T-OPLL patients [26]. rs199772854, rs76999397, and rs189013166 in IL17RC were potential pathogenic loci for T-OPLL in the northern Chinese Han population. The current study showed that the A allele frequency of rs199772854 was higher in T-OPLL cases than in controls, which implied that the A allele could be a risk factor for the genetic susceptibility to T-OPLL and that the “CA” genotype enhanced the probability of T-OPLL susceptibility. The A allele frequency of rs76999397 was higher in T-OPLL cases than in controls, which implied that the A allele could be a risk factor for the genetic susceptibility to T-OPLL and that the ‘GA’ genotype was enhance the probability of T-OPLL susceptibility. In addition, the A allele frequency of rs189013166 was higher in T-OPLL cases than controls, which implied that the A allele could be a risk factor for the genetic susceptibility to T-OPLL and that the ‘GA’ genotype was enhance the probability of T-OPLL susceptibility. The IL17RC gene encodes a single-pass type I transmembrane protein located between the chromosomal regions 3p25.3 and 3p24.1, spanning approximately 16.55 kbp [27]. IL17RC has been implicated as an important regulator of bone metabolism that accelerates osteoblast differentiation. A recent study indicated that the IL17RC protein plays an indispensable role in osteoblastogenesis [28]. Moreover, the TGF-β signaling pathway is known to be associated with the initiation of ectopic ossification [29]. The IL17RC gene may also be involved in bone metabolism through canonical TGF-β signaling. This study provides a basis for the study of the effects of these SNPs on OPLL in the future. There were some limitations in the present study. First, the power of bioinformatics analyses and damaging-variant prediction algorithms are limited. The results of allelic frequencies and genotype distributions showed that there is no homogeneity of the disease-related allele and homozygous allies of pathological related minor allies in any of the T-OPLL patients, suggesting that the T-OPLL disease has highly genetic heterogeneities and complex pathogenesis. In addition, we lacked studies of co-efficiency between the allies of these two genes. To accomplish these issues, further genetic and functional studies, including studies with more participants of other ethnicities, are needed to confirm these positive findings.

Conclusions

To the best of our knowledge, this is the first association study of T-OPLL susceptibility genes in Han Chinese patients. From the current analysis, we identified five new potential pathogenic loci for T-OPLL: rs201153092 and rs13051496 in the COL6A1 gene; and rs199772854, rs76999397, and rs189013166 in the IL17RC gene. The results of the current study may be beneficial for clarifying the molecular etiology of T-OPLL. Further genetic studies with more participants of other ethnicities are required to confirm these positive findings, and functional studies will further our understanding of this obscure disease.
  29 in total

1.  Complexes of matrilin-1 and biglycan or decorin connect collagen VI microfibrils to both collagen II and aggrecan.

Authors:  Charlotte Wiberg; Andreas R Klatt; Raimund Wagener; Mats Paulsson; John F Bateman; Dick Heinegård; Matthias Mörgelin
Journal:  J Biol Chem       Date:  2003-07-01       Impact factor: 5.157

2.  Genomewide linkage and linkage disequilibrium analyses identify COL6A1, on chromosome 21, as the locus for ossification of the posterior longitudinal ligament of the spine.

Authors:  Toshihiro Tanaka; Katsunori Ikari; Kozo Furushima; Akihiro Okada; Hiroshi Tanaka; Ken-Ichi Furukawa; Kenichi Yoshida; Toshiyuki Ikeda; Shiro Ikegawa; Steven C Hunt; Jun Takeda; Satoshi Toh; Seiko Harata; Toshiaki Nakajima; Ituro Inoue
Journal:  Am J Hum Genet       Date:  2003-09-04       Impact factor: 11.025

3.  Association of toll-like receptor 5 gene polymorphism with susceptibility to ossification of the posterior longitudinal ligament of the spine in korean population.

Authors:  Won-Suk Chung; Dong-Hyun Nam; Dae-Jean Jo; Jun-Hwan Lee
Journal:  J Korean Neurosurg Soc       Date:  2011-01-31

4.  COL6A1 polymorphisms associated with ossification of the ligamentum flavum and ossification of the posterior longitudinal ligament.

Authors:  Qingquan Kong; Xi Ma; Feng Li; Zhaoqing Guo; Qiang Qi; Weishi Li; Haifeng Yuan; Zili Wang; Zhongqiang Chen
Journal:  Spine (Phila Pa 1976)       Date:  2007-12-01       Impact factor: 3.468

5.  Allele-specific PCR in SNP genotyping.

Authors:  Muriel Gaudet; Anna-Giulia Fara; Isacco Beritognolo; Maurizio Sabatti
Journal:  Methods Mol Biol       Date:  2009

6.  MutationTaster2: mutation prediction for the deep-sequencing age.

Authors:  Jana Marie Schwarz; David N Cooper; Markus Schuelke; Dominik Seelow
Journal:  Nat Methods       Date:  2014-04       Impact factor: 28.547

7.  Ossification of the posterior longitudinal ligament of the spine.

Authors:  N Tsuyama
Journal:  Clin Orthop Relat Res       Date:  1984-04       Impact factor: 4.176

Review 8.  Ossification of the posterior longitudinal ligament: pathogenesis, management, and current surgical approaches. A review.

Authors:  Zachary A Smith; Colin C Buchanan; Dan Raphael; Larry T Khoo
Journal:  Neurosurg Focus       Date:  2011-03       Impact factor: 4.047

9.  A radiological population study on the ossification of the posterior longitudinal ligament in the spine.

Authors:  K Ohtsuka; K Terayama; M Yanagihara; K Wada; K Kasuga; T Machida; S Matsushima
Journal:  Arch Orthop Trauma Surg       Date:  1987

10.  Association between BMP-2 and COL6A1 gene polymorphisms with susceptibility to ossification of the posterior longitudinal ligament of the cervical spine in Korean patients and family members.

Authors:  K H Kim; S U Kuh; J Y Park; S J Lee; H S Park; D K Chin; K S Kim; Y E Cho
Journal:  Genet Mol Res       Date:  2014-03-31
View more
  7 in total

1.  Top 50 Most Cited Articles on Thoracic Ossification of Posterior Longitudinal Ligament.

Authors:  Xing Ding; Ming Yan; Jinze Wu; Chongqing Xu; Yinjie Yan; Zhixing Yu; Mengchen Yin; Jinhai Xu; Junming Ma; Wen Mo
Journal:  Front Surg       Date:  2022-05-09

2.  Association analysis and functional study of COL6A1 single nucleotide polymorphisms in thoracic ossification of the ligamentum flavum in the Chinese Han population.

Authors:  Xiaochen Qu; Xiaofei Hou; Zhongqiang Chen; Guanghui Chen; Tianqi Fan; Xiaoxi Yang
Journal:  Eur Spine J       Date:  2021-07-21       Impact factor: 3.134

3.  Potential role of the IL17RC gene in the thoracic ossification of the posterior longitudinal ligament.

Authors:  Peng Wang; Xiaoguang Liu; Chao Kong; Xiao Liu; Ze Teng; Yunlong Ma; Lei Yong; Chen Liang; Guanping He; Shibao Lu
Journal:  Int J Mol Med       Date:  2019-03-12       Impact factor: 4.101

Review 4.  Etiopathogenetic Mechanisms in Diverticular Disease of the Colon.

Authors:  Michael Camilleri; Robert S Sandler; Anne F Peery
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2019-07-25

5.  The COL6A1 rs201153092 single nucleotide polymorphism, associates with thoracic ossification of the posterior longitudinal ligament.

Authors:  Peng Wang; Ze Teng; Xiaoguang Liu; Xiao Liu; Chao Kong; Shibao Lu
Journal:  Mol Med Rep       Date:  2019-11-22       Impact factor: 2.952

6.  A rare cause of thoracic cord compression.

Authors:  Anderson Alexsander Rodrigues Teixeira; Lucas Fernandes Ferreira; Bruno Nunes Ferraz De Abreu; Euler Nicolau Sauaia Filho; Francisco Ramos Junior
Journal:  Surg Neurol Int       Date:  2018-09-21

7.  A new single nucleotide polymorphism affects the predisposition to thoracic ossification of the posterior longitudinal ligament.

Authors:  Peng Wang; Ze Teng; Xiaoguang Liu; Xiao Liu; Chao Kong; Shibao Lu
Journal:  J Orthop Surg Res       Date:  2019-12-12       Impact factor: 2.359

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.